422 related articles for article (PubMed ID: 31823819)
1. Benefits and harms of medical cannabis: a scoping review of systematic reviews.
Pratt M; Stevens A; Thuku M; Butler C; Skidmore B; Wieland LS; Clemons M; Kanji S; Hutton B
Syst Rev; 2019 Dec; 8(1):320. PubMed ID: 31823819
[TBL] [Abstract][Full Text] [Related]
2. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms.
Allan GM; Finley CR; Ton J; Perry D; Ramji J; Crawford K; Lindblad AJ; Korownyk C; Kolber MR
Can Fam Physician; 2018 Feb; 64(2):e78-e94. PubMed ID: 29449262
[TBL] [Abstract][Full Text] [Related]
4. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
[TBL] [Abstract][Full Text] [Related]
7. Cannabis and Radiation Therapy: A Scoping Review of Human Clinical Trials.
Rosewall T; Feuz C; Bayley A
J Med Imaging Radiat Sci; 2020 Jun; 51(2):342-349. PubMed ID: 32249134
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review.
Nugent SM; Morasco BJ; O'Neil ME; Freeman M; Low A; Kondo K; Elven C; Zakher B; Motu'apuaka M; Paynter R; Kansagara D
Ann Intern Med; 2017 Sep; 167(5):319-331. PubMed ID: 28806817
[TBL] [Abstract][Full Text] [Related]
9. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
Krcevski-Skvarc N; Wells C; Häuser W
Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
Häuser W; Petzke F; Fitzcharles MA
Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533
[TBL] [Abstract][Full Text] [Related]
11. Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature.
Wolfe D; Corace K; Butler C; Rice D; Skidmore B; Patel Y; Thayaparan P; Michaud A; Hamel C; Smith A; Garber G; Porath A; Conn D; Willows M; Abramovici H; Thavorn K; Kanji S; Hutton B
PLoS One; 2023; 18(2):e0281826. PubMed ID: 36800328
[TBL] [Abstract][Full Text] [Related]
12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids for symptom management in children with cancer: A systematic review and meta-analysis.
Chhabra M; Ben-Eltriki M; Paul A; Lê ML; Herbert A; Oberoi S; Bradford N; Bowers A; Rassekh SR; Kelly LE
Cancer; 2023 Nov; 129(22):3656-3670. PubMed ID: 37635461
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease.
Ng L; Khan F; Young CA; Galea M
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011776. PubMed ID: 28072907
[TBL] [Abstract][Full Text] [Related]
15. Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.
Inglet S; Winter B; Yost SE; Entringer S; Lian A; Biksacky M; Pitt RD; Mortensen W
Ann Pharmacother; 2020 Nov; 54(11):1109-1143. PubMed ID: 32483988
[TBL] [Abstract][Full Text] [Related]
16. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Whiting PF; Wolff RF; Deshpande S; Di Nisio M; Duffy S; Hernandez AV; Keurentjes JC; Lang S; Misso K; Ryder S; Schmidlkofer S; Westwood M; Kleijnen J
JAMA; 2015 Jun 23-30; 313(24):2456-73. PubMed ID: 26103030
[TBL] [Abstract][Full Text] [Related]
19. Cannabis for the treatment of Crohn's disease.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
[TBL] [Abstract][Full Text] [Related]
20. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
Parmar JR; Forrest BD; Freeman RA
Res Social Adm Pharm; 2016; 12(4):638-54. PubMed ID: 26443472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
